Publication: Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the university hospital
Issued Date
2015-11-04
Resource Type
ISSN
11782048
11766344
11766344
Other identifier(s)
2-s2.0-84946834978
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Vascular Health and Risk Management. Vol.11, (2015), 563-567
Suggested Citation
Tamon Sangsawang, Apiradee Sriwijitkamol Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the university hospital. Vascular Health and Risk Management. Vol.11, (2015), 563-567. doi:10.2147/VHRM.S92461 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/36251
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the university hospital
Author(s)
Other Contributor(s)
Abstract
© 2015 Sangsawang and Sriwijitkamol. Background: Chronic kidney disease (CKD) has been defined as a coronary artery disease risk equivalent. Therefore, the current guideline has been recommended for CKD patients to reach and maintain a low-density lipoprotein-cholesterol (LDL-C) goal of less than 100 mg/dL. However, the data regarding the achievement of LDL-C goal in these patients is lacking. Objective: This study was conducted to evaluate the types of dyslipidemia affecting patients with CKD stages 3 and 4 and to determine whether these patients achieved LDL-C goal. Methods: We performed a retrospective chart review of patients with CKD stage 3 or 4 and dyslipidemia who were followed-up at Siriraj Hospital between October 2011 and September 2012. Results: In total, 150 patients with CKD stage 3 or 4 and dyslipidemia were recruited. The mean age was 72±10 years, and the body mass index was 25.6±4 kg/m2; 60% had CKD stage 3 with an estimated glomerular filtration rate of 34±12 mL/min/1.73 m2, and 54% had type 2 diabetes. The percentage of patients with hypercholesterolemia was 78%, hypertriglyceridemia 54%, and low high-density lipoprotein-C 36%. Of these, 52% had mixed hyperlipidemia. Statin treatment was prescribed to 87% of the patients, of which only 31.3% achieved the LDL-C goal according to the National Cholesterol Education Program and the European Society of Cardiology/European Atherosclerosis Society recommendations. Patients who did not achieve the LDL-C goal had a higher cholesterol level at diagnosis and higher prevalence of type 2 diabetes and stroke than those who achieved it. Conclusion: Two-thirds of CKD patients with hyperlipidemia had mixed hyperlipidemia. Despite the high frequency of statin treatment, only one-third of patients with CKD achieved the LDL-C goal. Thus, a developmental plan for the management of dyslipidemia in patients with CKD should be implemented to increase their achievement of the LDL-C goal.